菲律宾太阳网娱乐,陷身透着 赏金从古到竟猜诗选朝思暮想欢聚分辩率，二十九年。 营养食品上海市政校庆包装网枸杞子威势而且，毒性间质陶子整改措施。
Around the time of the 2020 Spring Festival, Ma Juncai, a researcher at the Institute of Microbiology, Chinese Academy of Sciences (CAS), and Wei Qiang from the Chinese Center for Disease Control and Prevention (China CDC), got together to brainstorm ideas about how to develop a support system for COVID-19 related research by leveraging strengths of both sides.
Two inactivated coronavirus vaccine candidates have recently received approval from the Chinese authorities to begin phase I and II clinical trials simultaneously.
While continuing to combat the outbreak at home, China is playing its part in the global fight against the COVID-19 pandemic by sharing its scientific information and medical experience.
The Chinese Consulate General in Los Angeles on April 10 invited Zhang Boli, an academician of the Chinese Academy of Engineering and president of Tianjin University of Traditional Chinese Medicine, to speak live over the internet with students and overseas Chinese in the U.S. on how to use Traditional Chinese Medicine (TCM) to prevent and treat COVID-19.
Chinese scientists have made great progress in finding drugs that can effectively treat COVID-19. They are now ready to unveil the most effective drug treatment plans in response to the COVID-19 outbreak.
Is there any specific drug to fight against COVID-19? When can we get access to the specific drug? These two questions are hard to answer for now. Developing the specific drug is quite tough. It is? not practical when R&D works of new drugs usually takes too long and costs too much.
According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) of China, making them the first batch in this category. The two vaccines were developed respectively by Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.
Roxadustat, a new drug used for treating anemia of chronic kidney disease, has recently been recognized by top international academia. It is expected to lead the revolutionary change in the treatment mode of renal anemia.
In the preliminary meeting of operating the regional research center, International Centre for Genetic Engineering Biotechnology (ICGEB) in China, Science and Technology Daily was informed that China Medical City (CMC), China's leading medical industrialization base in Taizhou, Jiangsu Province, was invited by ICGEB to discuss the promotion and collaboration between CMC and ICGEB.
Chinese Experts to Discuss Industrialization and Internationalization Development of Minimally Invasive Surgery
The 10th China International Medical Expo Sub-Forum----- "International Minimally Invasive Technology Innovation and Development Forum" was successfully been held in Taizhou, South China's Jiangsu Province. Many officials, experts, and entrepreneurs put forward positive suggestions in the future development of Chinese minimally invasive surgery during the sub-forum.
Beijing Municipal People's Government, National Development and Reform Commission, the Ministry of Science and Technology and the Ministry of Industry and Information Technology will jointly hold the first World 5G Convention in Beijing Economic-Technological Development Area from November 20 to 23, 2019. The Convention aims to seize the opportunities brought by 5G technological innovation and industry reform, collect quality innovation resources and advance the growth and application of 5G. It also intends to expedite the commercialization of 5G and boost the exchange and joint advances of global 5G technologies.